Announcements Trials
Browse Landscape

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Observational 2

Sponsor

Cancer Type

CNS 2

Conditions

Breast Neoplasms 9Lung Neoplasms 5Prostatic Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Neoplasms 2Melanoma 2Glioma 2Colorectal Neoplasms 2Barrett Esophagus 2Adenocarcinoma of Lung 2Thyroid Nodule 1Thyroid Neoplasms 1Spinal Fractures 1Smoking Cessation 1Skin Neoplasms 1Recurrence 1Rectal Neoplasms 1Phyllodes Tumor 1Pancreatic Neoplasms 1Osteoporosis 1Nevus 1Neoplastic Cells, Circulating 1Multiple Pulmonary Nodules 1Lymphoma, Follicular 1Lung Diseases 1Locally Advanced Pancreatic Cancer 1Liver Cirrhosis 1Inflammatory Bowel Diseases 1Hypertension, Portal 1Head and Neck Neoplasms 1

Interventions

Temozolomide 109Magnetic Resonance Spectroscopy 52Bevacizumab 52Radiotherapy 44Irinotecan 27Blood Specimen Collection 19Surgical Procedures, Operative 16Radiation 15Aminolevulinic Acid 15Carboplatin 13fluorodopa F 18 12Nivolumab 12Radiotherapy, Intensity-Modulated 11Carmustine 11Radiosurgery 10Magnetic Resonance Imaging 10pembrolizumab 9Topotecan 9Specimen Handling 9Everolimus 9Erlotinib Hydrochloride 9Biopsy 9poly ICLC 8Surveys and Questionnaires 8Standard of Care 8Etoposide 8Drug Therapy 8Lomustine 7Filgrastim 7Cyclophosphamide 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Glioma × Diagnostic Imaging × Clear all
NCT05274919 2025-03-10

VASIM

Leiden University Medical Center

Recruiting
180 enrolled
CNS

Glioma

NCT00137488 2016-02-26

Angiogenic Profile and Non-invasive Imaging May Predict Tumor Progression of High Risk Group Low Grade Glioma (LGG)

AHS Cancer Control Alberta

Completed
10 enrolled
CNS

Glioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡